Tavros was founded with a mission to discover novel targeted cancer therapies using cutting edge genomics technologies to improve outcomes for cancer patients.
Our leadership team is comprised of successful serial entrepreneurs with deep expertise in functional genomics, tumor genetics and drug discovery.